Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Holders of 5% or more of RIGL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Rigel Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.70%1.38M shares | −2.20 ppfrom 9.90% | Feb 5, 20252 filings | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Rigel Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20256:22 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 3.99%724.0K shares | −4.93 ppfrom 8.92%Below 5% | Sep 30, 2025 | SEC |
| Oct 7, 20254:15 PM ET | Morgan Stanleyand 1 other | 13G/A | 0.70%116.4K shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20259:31 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 8.92%1.60M shares | +0.44 ppfrom 8.48% | Jun 30, 2025 | SEC |
| Aug 5, 20255:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 3.70%658.1K shares | −2.70 ppfrom 6.40%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:46 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 8.48%1.52M shares | +1.94 ppfrom 6.54% | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 7.70%1.38M shares | −2.20 ppfrom 9.90% | Mar 31, 2025 | SEC |
| Feb 14, 20255:18 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 6.54%1.15M shares | – | Dec 31, 2024 | SEC |
| Feb 11, 20254:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 6.40%1.13M shares | – | Dec 31, 2024 | SEC |
| Feb 7, 20251:42 PM ET | Invesco Ltd. | 13G/A | 0.00%6.45K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G | 9.90%1.75M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Rigel Pharmaceuticals Inc shares.
No Form 144 notices for Rigel Pharmaceuticals Inc are on file.